Skin toxicity after chest wall/breast plus level III-IV lymph nodes treatment with helical tomotherapy.
To evaluate the incidence of toxicity in breast cancer with helical tomotherapy (HT). 51 patients with breast cancer were assigned to postoperative radiotherapy by means of HT to the chest wall/breast plus draining nodes. During HT treatment, toxicity was monitored and were assessed using the Common Terminology Criteria for Adverse Events 4.0 scale. Acute skin G3 toxicity observed in 1.9% cases. No acute or late G4 toxicity was observed. At a median follow-up of 21 months 2 patients have late G1 toxicity. HT was associated with a low incidence of low-grade skin toxicity.